When the Aortic Bioprosthesis Degenerates: Revalve or Replace?
This American multicenter retrospective study evaluates the medium-term outcomes of patients with degenerated aortic bioprostheses who underwent either percutaneous valve-in-prosthesis procedures or reoperation for valve replacement.
Transplantation in Fontan: an expert’s perspective
A review commentary on the complex topic of heart transplantation in patients with Fontan circulation physiology, authored by expert Dr. Juan-Miguel Gil-Jaurena.
Pocket Summary of the 2024 Atrial Fibrillation Guidelines
Summary of the new 2024 European Society of Cardiology guidelines on atrial fibrillation.
Spain, 17 countries in one… also in terms of infective endocarditis epidemiology
Epidemiological study on the prevalence and regional differences in etiologies, treatment, and outcomes of infective endocarditis in Spain.
Balloon-Expandable Myval® Bioprosthesis Matches Contemporary Devices: A Surgeon’s Perspective
Randomized Clinical LANDMARK Non-Inferiority Trial Comparing the Meril Myval® Balloon-Expandable Prosthesis with Widely Used Contemporary Prostheses (Edwards SAPIEN® and Medtronic Evolut®) in Transcatheter Aortic Valve Implantation
PCI versus Surgery for Left Main Coronary Artery Disease According to Age: The Last Surgical Frontier at Risk?
A meta-analysis including 4 randomized controlled trials and 10 observational studies comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in left main coronary artery (LMCA) disease according to patient age.
Patent ductus arteriosus in very-low-birth-weight preterm infants: is there a place for early surgery?
This retrospective study evaluates the outcomes of surgical closure of haemodynamically significant patent ductus arteriosus (hsPDA) in very-low-birth-weight preterm neonates.
Biological Aortic Valve Replacement in Young Patients with Bicuspid Aortic Valve: Is It Still a Viable Option?
This article analyzes outcomes from 498 patients under the age of 65 with bicuspid aortic valve (BAV) undergoing aortic valve replacement (AVR) with bioprostheses due to aortic stenosis (AS).
